NPM1 has been reported to epigenetically regulate PD-L1 expression in breast cancer, and once bound to poly (ADP-ribose) polymerase-1 (PARP1), NPM1 loses the ability to activate PD-L1 [11]. The gene discussed is NPM1; the disease is breast carcinoma.